London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bicycle Therapeutics are also at the Boston Conf #SIT22
https://investors.bicycletherapeutics.com/news-releases/news-release-details/bicycle-therapeutics-present-five-posters-highlighting
Ankyra are based in Boston as well.
If there is any sign of a sell off I will be dipping my toes and foot in..
In fact both feet....fingers crossed for a sell off....
Looking at some of the trades today, at least 4 are matched trades. 4 traders lost money today by being impatient. Look at the 47k 39lk and the 12k trades.
It would be typical of PYC for a sell off to happen tomorrow with no news.
Thanks for info Kidlington... I might dip my toe in further tomorrow.
Nice to see continued follow-on biz from Ankyra.
Freddie, no sign of institutional investor(s) here that i know of, last institution that took up some shares was Canaccord in the last raise in 2020.
Notice as soon as news broke, the MM's made hay, but at least they have a nice 3.8% spread by the end of the day.
Quite a few trades you can see that are matched, and they all bought high, and sold low.......go figure!
Hi tapen
But £1mln revenues for a £2.5mln company with £700k cash (which will last 2 -3yrs) is the important bit
Many companies have £1mln revenues but have market values of £20mln and more
So actually the revenues are impressive, particularly given its been a record year for growth and highest ever revenues
I cannot see that anyone has staked more than £1,000 in these shares this afternoon (in a single trade). I guess this reflects the risk here but the shares do look compelling at this level so I'll pitch in tomorrow all being well.
Last year PYC employed a new Business Head of Development and 2 technical staff, at considerable cost.
Finally they seem to be actively looking for new business, and if they do achieve, then the share price could see considerable gains. A turnover of less than £1 million isn't impressive, however a lot of potential customers have big budgets.
There are less than 100 million ordinary shares issued, therefore a purchase of 100,000 shares is 0.1% of the company, a considerable lump in one trade.
This can move extremely quickly if people start buying in.
Hi Laura...thanks for your post....I have dipped my toe in this afternoon .as it looks like there's plenty of interest in the stock and its all buys ....level 2 suggesting a tick up early tomorrow ....fingers crossed.
Have a nice evening and great to make your acquaintance.
Best wishes Freddie
Do they not offer a Tel service Laura whereby you can either set a ‘kill or Fill ‘ limit for the day which may or not be filled or ‘at best’ which whilst a little risky can sometimes come inside the ask especially when dealing with brokers who are also market makers like Jarvis.I often find I’m quoted better prices via phone than online.
Hi Freddie
Others here are more knowledgeable as I started investing in 2 bio techs this year , PYC being one of them
I have been adding more the last few weeks but frustratingly HL only allow £2500 or so as a maximum buy or won't give an electronic quote
People on here suggest I change provider but a friend on IG says today its the same , about 100 000 shares maximum
Hi Laura and thanks for sharing your research with me......I guess I may have to sell other stock to buy in...but at this price and mindful the afternoon buyer hasn't moved the sp, perhaps I may come in tomorrow.
Good to hear someone is on the helm....Best of luck Laura.
Freddie
Hi Freddie
Pyc work in a multi billion pound cancer sector , they are working with 20 or more well known global pharmaceutical companies with huge budgets
PYC are only listed comapny in UK who can save time and money for designing oncology drugs using computer modeling
The £2.5 million marker value is ludicrous given pyc have loads of cash and record revenues approaching £1mln per year
....may be interested as physiomic's well funded with a first-class new customer......?
thoughts anyone ...or is this LSE's answer to the Marie Celeste
Bit more money going on......that's good news
data
........based on level 2 date
Since this JULY update the company has continued to win more contracts amd the actually fixed monthly overbheads are very low , but you clearly wouldn't know that
Maybe you should focus on pontificating on MAFL etc
" Company's cash position remains strong, with £687k at the bank as at 30 June 2022, representing almost two years of cash runway. "
Really is strange nomlungu that you spend all your time on shares you don't own,UKOG VAL and PYC
One can only assume you're lonely
As for cash please at least read the RNSs
There is AT LEAST TWO YEARS CASH RUNWAY as stated in RNSs this year, and probably more than 3years
Also presenting today at SITC22.
Posters and Presentations
November 10, 2022 Society for Immunotherapy of Cancer (SITC) Presentation: Anchored immunotherapy with intratumorally administered aluminum hydroxide-tethered IL-12 induces potent anti-tumor immune response
https://ankyratx.com/wp-content/uploads/2022/11/2022-11-03_-SITC-Poster_Battula_final_ID1076.pdf
"Lots of new contracts and lots of cash"
Does the company make taxable profit and free cash flow? If not, when is this expected to happen? Is the company still burning around £60k a month? How long will the June cash balance of £687k last? Will there be a placing in the 1st half of next year?
VAL201 could also add a large sum in the ££mlns as alluded to in the VAL presentation this week
Kidlington put a link I think?
Compared to other expensive bio techs with little or no revenues and need for xash PYC is in an excellent position
Lots of new contracts and lots of cash
In fact the cash is one third of the market value
Scoopy. Same here with sar. It's very disappointing that they seem unable to sell their products!!! I've sold half my holding in sar once they made yet another shock rns Tuesday after hours. I've bought back in here this morning since pyc are actually selling their products . Perhaps more will come from sar and buy pyc.
There’s not a lot of stock about